Patrick Kristin's Form 4 filing
Niagen Bioscience, Inc. (NAGE) · filed Aug 26, 2024
- Accession no.
- 0001628280-24-038470
- Filed
- Aug 26, 2024
- Trade date
- Aug 23, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $82.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patrick KristinCIK 0001769529 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | Common Stock | MOption exerciseAcquired | +3,000 | $1.64 | +$4,920 | 3,000 | Direct | |
| Aug 23, 2024 | Common Stock | MOption exerciseAcquired | +20,000 | $1.67 | +$33,400 | 23,000 | Direct | |
| Aug 23, 2024 | Common Stock | SSaleDisposed | −23,000 | $3.57 | −$82,110 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 17,000 | Direct | |
| Aug 23, 2024 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.